Acute pancreatitis is one of the most common causes of abdominal pain in patients presenting to the emergency room. It is an ...
The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).
Morning Overview on MSN
The FDA cleared a new drug to lower dangerously high triglycerides and cut pancreatitis risk
Adults with dangerously elevated blood fats now have the first approved drug shown to cut their risk of acute pancreatitis, a ...
Acute pancreatitis (AP) remains a major medical challenge, with high morbidity and no approved drug that directly alters its course. Recent advances reveal that the earliest and most critical trigger ...
The severity of acute pancreatitis poses substantial prognostic challenges for healthcare clinicians, with new or persistent SIRS or elevated BUN levels indicating severe progression. Researchers ...
Ionis has forecast peak sales of $2bn for Tryngolza as it seeks to harness first-mover advantage.
TRYNGOLZA (olezarsen) is indicated as an adjunct to diet to reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). TRYNGOLZA is indicated as an adjunct to diet to reduce TG ...
Fluid resuscitation in acute pancreatitis shows crystalloid type and rate interaction influencing hospital length of stay in mild cases.
Pancreatitis, an inflammation of the pancreas, comes in two forms: acute and chronic. Acute pancreatitis is the most common form of the condition and often subsides after a few days of treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results